NCT00914641 - Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Thrombosis

Interventions

DRUG

Apixaban IR

immediate release tablet, 10 mg, single dose

DRUG

Apixaban MR1

modified release tablet 1, 10 mg, single dose

DRUG

Apixaban MR2

modified release tablet 2, 10 mg, single dose

DRUG

Apixaban MR3

modified release tablet 3, 10 mg, single dose

Trial Locations (1)

Pfizer Investigational Site, New Haven